Takeda Pharmaceutical Company Limited Accounting Profit
Takeda Pharmaceutical Company Limited (TKPHF) reported Accounting Profit of JPY 175.08 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:AccountingProfit · last filed 2025-06-25
| Period end | Accounting Profit 12 month |
|---|---|
| 2025-03-31 | 175.08B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 52.79B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 375.09B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 302.57B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 366.24B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | -60.75B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 127.61B JPY 20-F · filed 2021-06-29 |